Cargando…

Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study

Recent studies raised concerns about the increasing use of gabapentinoids in different countries. With their potential for misuse and addiction, understanding the global consumption of gabapentinoids will offer us a platform to examine the need for any interventional policies. This longitudinal tren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Adrienne Y. L., Yuen, Andrew S. C., Tsai, Daniel H. T., Lau, Wallis C. Y., Jani, Yogini H., Hsia, Yingfen, Osborn, David P. J., Hayes, Joseph F., Besag, Frank M. C., Lai, Edward C. C., Wei, Li, Taxis, Katja, Wong, Ian C. K., Man, Kenneth K. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435503/ https://www.ncbi.nlm.nih.gov/pubmed/37591833 http://dx.doi.org/10.1038/s41467-023-40637-8

Ejemplares similares

Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study
por: Chan, Adrienne Y.L., et al.
Publicado: (2023)

Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study
por: Brauer, Ruth, et al.
Publicado: (2021)

Antibiotic prescribing in general practice during COVID-19 and beyond
por: Bryant, Olivia K, et al.
Publicado: (2023)

Gabapentinoids for Pruritus in Older Adults: A Narrative Review
por: Sreekantaswamy, Shreya A., et al.
Publicado: (2021)

Risk of respiratory depression with opioids and concomitant gabapentinoids
por: Savelloni, Julie, et al.
Publicado: (2017)

Antipsychotic polypharmacy and adverse drug reactions among adults in a London mental health service, 2008–2018
por: Yang, Justin C., et al.
Publicado: (2023)

Current Evidence on Abuse and Misuse of Gabapentinoids
por: Hägg, Staffan, et al.
Publicado: (2020)

Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries
por: Pathadka, Swathi, et al.
Publicado: (2022)

The importance of cache domains in α(2)δ proteins and the basis for their gabapentinoid selectivity
por: Page, Karen M, et al.
Publicado: (2023)

Pain And The Use Of Gabapentinoids In German Nursing Home Residents - Results From An Analysis Based On Statutory Health Insurance Data
por: Bantel, C, et al.
Publicado: (2019)

Gabapentinoids: Gabapentin and Pregabalin for Postoperative Pain Management
por: Imani, Farnad, et al.
Publicado: (2012)

Fatalities associated with gabapentinoids in England (2004–2020)
por: Kalk, Nicola J., et al.
Publicado: (2022)

A snapshot on the usage pattern of gabapentinoids in Oman
por: Badi, Abdulaziz Said Al, et al.
Publicado: (2022)

Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries
por: Fonseca, Francina, et al.
Publicado: (2021)

Evaluation of the England Community Pharmacy Quality Scheme (2018–2019 and 2019–2020) in reducing harm from NSAIDs in older patients
por: Parekh, Sejal, et al.
Publicado: (2023)

Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34 European and North American countries
por: Ju, Chengsheng, et al.
Publicado: (2021)

Risk of respiratory depression with opioids and concomitant gabapentinoids [Corrigendum]
Publicado: (2018)

Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)

Opioid and gabapentinoid prescriptions in England from 2015 to 2020
por: Xia, Yixue, et al.
Publicado: (2022)

Trazodone use and risk of dementia: A population-based cohort study
por: Brauer, Ruth, et al.
Publicado: (2019)

Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)

Gabapentinoid Prescribing Practices at a Large Academic Medical Center
por: Huang, Linda L., et al.
Publicado: (2023)

Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trial
por: Williams, Jerome, et al.
Publicado: (2022)

Mirogabalin as a Novel Gabapentinoid for the Treatment of Chronic Pain Conditions: An Analysis of Current Evidence
por: Chen, Eric Y., et al.
Publicado: (2021)

Mechanisms of the gabapentinoids and α (2) δ‐1 calcium channel subunit in neuropathic pain
por: Patel, Ryan, et al.
Publicado: (2016)

Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016
por: Zhou, Lili, et al.
Publicado: (2019)

Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
por: Tambon, Marine, et al.
Publicado: (2021)

Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: McAnally, Heath B., et al.
Publicado: (2021)

Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults
por: Bongiovanni, Tasce, et al.
Publicado: (2023)

Considerations When Using Gabapentinoids to Treat Trigeminal Neuralgia: A Review
por: De Stefano, Gianfranco, et al.
Publicado: (2023)

Trends and Factors Associated with Under-5 Mortality in Northwest Nigeria (2008–2018)
por: Ezeh, Osita K., et al.
Publicado: (2022)

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
por: Desai, Payal H., et al.
Publicado: (2021)

Complaints, Restraint, and Seclusion in Massachusetts Inpatient Psychiatric Facilities, 2008–2018
por: Shields, Morgan C., et al.
Publicado: (2023)

A 3D Tissue Model of Traumatic Brain Injury with Excitotoxicity That Is Inhibited by Chronic Exposure to Gabapentinoids
por: Rouleau, Nicolas, et al.
Publicado: (2020)

Time-series modelling and forecasting of hand, foot and mouth disease cases in China from 2008 to 2018
por: Tian, C. W., et al.
Publicado: (2019)

Clinical efficacy and tolerability of Gabapentinoids with current prescription patterns in patients with Neuropathic pain
por: Shaheen, Abida, et al.
Publicado: (2019)

Effectiveness of Gabapentinoids for Cancer-related Rectal and Vesical Tenesmus: Report of Four Cases
por: Tagami, Keita, et al.
Publicado: (2020)

Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: Peckham, Alyssa M., et al.
Publicado: (2021)

Mirogabalin, a selective gabapentinoid for managing neuropathic pain—A curtain raiser
por: Nair, Abhijit
Publicado: (2022)

The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids
por: Tang, Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mn8h3pkgro2hft1alincfsmidk